The prevalence of chronic hypertension in pregnancy in the United States doubled from 2007-2021, but only about 60% of those with the potentially life-threatening condition were treated with antihypertensive medications, according to a National Institutes of Health (NIH)-supported study of nearly 2 million pregnancies. The study, which was funded by NIH’s National Heart, Lung, and Blood Institute (NHLBI), did not explore the reasons for the increase, but rising maternal age, growing obesity rates, and other factors likely played a role, according to researchers. The findings were published in the journal Hypertension.
Biotech company Rocketvax AG’s RVX-sCPD9 candidate for the prevention of SARS-CoV-2 has been selected to be part of Project NextGen, an initiative by the U.S. Department of Health and Human Services aimed at advancing a pipeline of new, innovative vaccines providing broader and more durable protection against COVID-19.
A pilot program from the National Institutes of Health will set up clinical research at primary care centers serving underrepresented patients.
Against a backdrop of low-volume but growing concerns about bird flu, the NIH's NIAID has laid out a plan to study the virus that causes the illness.
As part of Pluri’s previously announced $4.2 million 3-year contract with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), the option for the second year of the contract has...
The Foundation for the National Institutes of Health Awards 2024 Lurie Prize in Biomedical Sciences to Howard Y. Chang, M.D., Ph.D.
The Foundation for the National Institutes of Health Appoints James W. Down and Perry Steiner to Its Board of Directors
The Foundation for the National Institutes of Health Announces the Launch of a Public-Private Partnership to Accelerate ALS Diagnosis and Treatment
CLS Americas received its second order from the National Institutes of Health Clinical Center (NIHCC) for its TRANBERG Thermal Therapy System accessories.
The National Institutes of Health (NIH) researchers have discovered a specific network of proteins that is necessary to restore hearing in zebrafish through cell regeneration. The study, led by investigators at the National Human Genome Research Institute (NHGRI), may inform the development of treatments for hearing loss in humans. The findings were published in Cell Genomics.